Richard A. Bierly

Biography

 Richard A. Bierly was appointed to Aclaris Therapeutics’ board of directors on October 2015. Most recently, he served as Vice President and Chief Financial Officer of Medivation, Inc., a Nasdaq-listed biopharmaceutical company, for over two years prior to his retirement in July 2016. Prior to joining Medivation, Inc., Mr. Bierly served as an Executive Director in Ernst & Young LLP's Financial Accounting Advisory Services practice for life sciences and other clients. Mr. Bierly also worked more than twelve years in several leadership roles at Johnson & Johnson (JNJ), including as Vice President, Global Finance Services. During his tenure at JNJ, Mr. Bierly also served as Vice President, Finance of Centocor, Inc., and as Vice President, Finance, of Ortho Biotech LP (both subsidiaries of JNJ). Before joining JNJ, he held various staff and leadership positions in finance and accounting at Aventis, SmithKline and Ernst & Young LLP. He received a Bachelor of Business Administration from Pennsylvania State University and is a certified public accountant in Pennsylvania (inactive) and New Jersey (inactive). Mr. Bierly has over 30 years of experience in the pharmaceutical/biotechnology industry, and he also serves on the board of directors of Impax Laboratories, Inc.

Research Interest

 Financial